503 related articles for article (PubMed ID: 3018081)
1. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
Borish L; O'Reilly D; Klempner MS; Rocklin RE
J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
[TBL] [Abstract][Full Text] [Related]
2. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
Seligmann BE; Fletcher MP; Gallin JI
J Immunol; 1983 Apr; 130(4):1902-9. PubMed ID: 6131922
[TBL] [Abstract][Full Text] [Related]
3. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
4. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
Fletcher MP; Seligmann BE; Gallin JI
J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
[TBL] [Abstract][Full Text] [Related]
5. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.
Weisbart RH; Golde DW; Gasson JC
J Immunol; 1986 Dec; 137(11):3584-7. PubMed ID: 3491142
[TBL] [Abstract][Full Text] [Related]
6. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
Marasco WA; Feltner DE; Ward PA
J Cell Biochem; 1985; 27(4):359-75. PubMed ID: 2987275
[TBL] [Abstract][Full Text] [Related]
7. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.
Atkinson YH; Lopez AF; Marasco WA; Lucas CM; Wong GG; Burns GF; Vadas MA
Immunology; 1988 Jul; 64(3):519-25. PubMed ID: 2842255
[TBL] [Abstract][Full Text] [Related]
10. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
Donabedian H; Gallin JI
J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
[TBL] [Abstract][Full Text] [Related]
12. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Becker EL
J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
[TBL] [Abstract][Full Text] [Related]
14. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression.
Zimmerli W; Seligmann B; Gallin JI
J Clin Invest; 1986 Mar; 77(3):925-33. PubMed ID: 3005369
[TBL] [Abstract][Full Text] [Related]
15. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
Mackin WM; Huang CK; Becker EL
J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
[TBL] [Abstract][Full Text] [Related]
16. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
Andersson T; Dahlgren C; Pozzan T; Stendahl O; Lew PD
Mol Pharmacol; 1986 Nov; 30(5):437-43. PubMed ID: 2430168
[TBL] [Abstract][Full Text] [Related]
17. Organelle-depleted human neutrophil cytoplasts used to study fmet-leu-phe receptor modulation and cell function.
Gallin JI; Metcalf JA; Roos D; Seligmann B; Friedman MM
J Immunol; 1984 Jul; 133(1):415-21. PubMed ID: 6327824
[TBL] [Abstract][Full Text] [Related]
18. Mobilization and adaptation of human neutrophil chemoattractant fMet-Leu-Phe receptors.
Gallin JI; Seligmann BE
Fed Proc; 1984 Sep; 43(12):2732-6. PubMed ID: 6088296
[TBL] [Abstract][Full Text] [Related]
19. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Showell HJ; Freer RJ; Becker EL
J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
[TBL] [Abstract][Full Text] [Related]
20. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
Beswick PH; Kay AB
Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
